Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-23-014751

Chief Accounting Officer sold 10,000 shares at $23.60 ($236,000)

  • Chief Accounting Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas Chief Accounting Officer 2023-06-06 Option exercise +10,000 $11.35 $113,500 15,132 D
Lyon Joseph Douglas Chief Accounting Officer 2023-06-06 Sale −10,000 $23.60 $236,000 5,132 D
Derivatives
Lyon Joseph Douglas Chief Accounting Officer 2023-06-06 Option exercise · Stock option (right to buy) −10,000 56,571 D
Open-market sales · 10,000 sh · avg $23.60 · $236,000
Loading xslF345X04/doc4.xml…